Browsing by Author "Handgretinger, R."

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Consensus of German Transplant Centers on Hematopoietic Stem Cell Transplantation in Fanconi Anemia
    (Thieme, 2015) Chao, M. M.; Ebell, W.; Bader, P.; Beier, R.; Burkhardt, B.; Feuchtinger, T.; Handgretinger, R.; Hanenberg, H.; Koehl, U.; Kratz, C.; Kremens, B.; Lang, P.; Meisel, R.; Mueller, I.; Roessig, C.; Sauer, M.; Schlegel, P. G.; Schulz, A.; Strahm, B.; Thol, F.; Sykora, K. W.; Department of Pediatrics, Indiana University School of Medicine
    Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10–15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.